ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial

NCT00161070 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

4500

Enrollment

OTHER

Sponsor class

Conditions

Brain Ischemia
Transient Ischemic Attack
Arteriosclerosis

Interventions

DRUG: anticoagulation
DRUG: aspirin and dipyridamole
DRUG: aspirin alone

Sponsor

UMC Utrecht